CHRS
Coherus Oncology·NASDAQ
--
--(--)
--
--(--)
CHRS Filings
Filing Date
Form Description
Form Type
2026-03-09
Coherus Oncology, Inc. (CHRS) Q4 2025 Earnings Call Transcript
Earnings Call
2026-03-09 · Earnings Call
Coherus Oncology, Inc. (CHRS) Q4 2025 Earnings Call Transcript
2026-03-09
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Financials
2026-03-09 · Financials
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026-03-09
Form 8-K - Current report
Key Events
2026-03-09 · Key Events
Form 8-K - Current report
2026-02-17
Form 8-K - Current report
Key Events
2026-02-17 · Key Events
Form 8-K - Current report
2026-02-13
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-02-13 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-02-12
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-02-12 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-02-05
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-02-05 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-02-04
Form 8-K - Current report
Key Events
2026-02-04 · Key Events
Form 8-K - Current report
2026-01-30
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-30 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-26
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-26 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
